These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11455860)

  • 21. Immunotherapeutic Targeting in Autoimmune Diseases.
    Janikashvili N; Samson M; Magen E; Chikovani T
    Mediators Inflamm; 2016; 2016():1432702. PubMed ID: 28074079
    [No Abstract]   [Full Text] [Related]  

  • 22. CAR T-Cell Therapy in Autoimmune Disease. Reply.
    Müller F; Mackensen A; Schett G
    N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
    [No Abstract]   [Full Text] [Related]  

  • 23. Selfie: Autoimmunity, boon or bane.
    Ahsan H
    J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immobilized antigenic preparations with magnetic properties in the diagnosis and treatment of rheumatic diseases].
    Zborovskiĭ AB; Gontar' IP
    Vestn Ross Akad Med Nauk; 1999; (5):45-9. PubMed ID: 10394301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus--an autoimmune disease?
    Holborow EJ
    J Clin Pathol Suppl (R Coll Pathol); 1978; 12():144-9. PubMed ID: 365887
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenic functions of B cells in autoimmune diseases: IFN-γ production joins the criminal gang.
    Fillatreau S
    Eur J Immunol; 2015 Apr; 45(4):966-70. PubMed ID: 25727209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnancy in systemic autoimmune diseases].
    Held E
    Internist (Berl); 1992 Feb; 33(2):90-9. PubMed ID: 1568833
    [No Abstract]   [Full Text] [Related]  

  • 28. [Etiopathogenesis of systemic lupus erythematosus].
    Mathian A
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S298-301. PubMed ID: 17964004
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in Lymphocyte cell surface markers in human disease states.
    Williams RC
    Clin Immunol Rev; 1981-1982; 1(3):409-69. PubMed ID: 6762279
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
    Miossec P
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis.
    Klareskog L; Rönnelid J; Gudmundsson S; Karlsson-Parra A
    Curr Opin Immunol; 1991 Dec; 3(6):912-6. PubMed ID: 1793535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mud therapy of rheumatoid arthritis in the aspect of the autoimmune concept of its pathogenesis].
    Litvinenko AG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1979; (1):22-7. PubMed ID: 311542
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis.
    Mota P; Reddy V; Isenberg D
    Expert Rev Clin Immunol; 2017 Jul; 13(7):667-676. PubMed ID: 27841031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The murine autoimmune diabetes model: NOD and related strains.
    Kikutani H; Makino S
    Adv Immunol; 1992; 51():285-322. PubMed ID: 1323922
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical applications of T, B, and K cell determinations in rheumatic diseases: a review.
    Scheinberg MA; Mendes NF; Kopersztych S; Cathcart ES
    Semin Arthritis Rheum; 1976 Aug; 6(1):1-18. PubMed ID: 785603
    [No Abstract]   [Full Text] [Related]  

  • 38. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.
    Kamradt T; Schubert D
    Arthritis Res Ther; 2005; 7(1):20-8. PubMed ID: 15642150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions.
    Indiveri F; Scudeletti M; Pierri I; Traverso A; Cerri C; Ferrone S
    Cell Immunol; 1986 Jan; 97(1):197-203. PubMed ID: 2943425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer T cells and rheumatoid arthritis: friend or foe?
    Elewaut D
    Arthritis Res Ther; 2005; 7(2):88-9. PubMed ID: 15743495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.